Formulary Updates
Posted on April 27, 2017
Health New England’s 2017 formularies are available on healthnewengland.org. We encourage Providers to utilize the online formularies, which are accessible to all users without a login or password.
The online formularies are updated throughout the year as changes are made. We have three formularies, one for each line of business – Commercial, Medicare Advantage and Be Healthy/Medicaid. Each formulary includes the tier assignment for each drug and any drug-specific medication management requirements, including quantity limitations, step therapy requirements and prior authorization requirements. For your convenience, when searching our Commercial and Medicaid formularies, you will find we have linked both clinical criteria and prior authorization forms.
Most recently the following medications have been reviewed, and changes will go into effect in May 2017:
- Addyi (Generic Name: Flibanserin)
- Auxipro Cream (Generic: Cream Base)
- Basaglar Pen (Generic Name: Insulin Glargine)
- Invokamet ER (Generic Name: Canaglifozin/Metformin)
In addition, the pharmacy changes related to our Semi-Annual Notice of Changes can be found here.
